Cargando…

Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, China

Background: The substitution of generic drugs can effectively alleviate the rapid growth of drug costs; however, the clinical effectiveness and medical costs of originator products and generics were barely studied in China. Objectives: To compare the effectiveness of antihypertensive drugs and hyper...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Tao, Bai, Lin, Wushouer, Haishaerjiang, Wang, Zhiyuan, Yang, Mingchun, Lin, Hongbo, Shen, Peng, Guan, Xiaodong, Shi, Luwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920543/ https://www.ncbi.nlm.nih.gov/pubmed/35295329 http://dx.doi.org/10.3389/fphar.2022.757398

Ejemplares similares

Health Care Utilization and Costs of Patients With Prostate Cancer in China Based on National Health Insurance Database From 2015 to 2017
por: Bai, Lin, et al.
Publicado: (2020)

Influence of Government Price Regulation on the Price, Volume and Spending of Antibiotics in China: A Controlled Interrupted Time Series Study
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Influence of government price regulation and deregulation on the price of antineoplastic medications in China: a controlled interrupted time series study
por: Guan, Xiaodong, et al.
Publicado: (2019)

Trends of Negotiated Targeted Anticancer Medicines Use in China: An Interrupted Time Series Analysis
por: Huang, Cong, et al.
Publicado: (2021)

The Impact of Sanming Healthcare Reform on Antibiotic Appropriate Use in County Hospitals in China
por: Hu, Lin, et al.
Publicado: (2022)

Medical insurance and healthcare utilization among the middle-aged and elderly in China: evidence from the China health and retirement longitudinal study 2011, 2013 and 2015
por: Zhou, Yue, et al.
Publicado: (2020)

Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
por: Huang, Cong, et al.
Publicado: (2022)

Outpatient prescribing pattern for acute bronchitis in primary healthcare settings in China
por: Fu, Mengyuan, et al.
Publicado: (2021)

Differences in reimbursement listing of anticancer therapies in China: an observational study
por: Guan, Xiaodong, et al.
Publicado: (2020)

The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China
por: Zhang, Yichen, et al.
Publicado: (2021)

Secular trend analysis of antibiotic utilisation in China’s hospitals 2011–2018, a retrospective analysis of procurement data
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Outpatient Antibiotic Prescribing Patterns and Appropriateness for Children in Primary Healthcare Settings in Beijing City, China, 2017–2019
por: Wushouer, Haishaerjiang, et al.
Publicado: (2021)

The impact of physicians’ knowledge on outpatient antibiotic use: Evidence from China's county hospitals
por: Wushouer, Haishaerjiang, et al.
Publicado: (2020)

Protocol of a tailored educational intervention for general practitioners on potentially inappropriate medications among older patients at community healthcare institutions in Beijing, China: a cluster-randomised controlled trial
por: Fu, Mengyuan, et al.
Publicado: (2021)

Inpatient antibacterial use trends and patterns, China, 2013–2021
por: Wushouer, Haishaerjiang, et al.
Publicado: (2023)

Utilization of Intravenous Ribavirin Among Reproductive Age Adults in 2010–2017: A Population-Based Study in the Yinzhou District, Ningbo City of China
por: Li, Hailong, et al.
Publicado: (2021)

Antibiotic use and irrational antibiotic prescriptions in 66 primary healthcare institutions in Beijing City, China, 2015–2018
por: Taxifulati, Yumiti, et al.
Publicado: (2021)

Acid Suppression Use Among Infants in One Tertiary Children's Hospital in China, 2015–2018: A Retrospective Observational Study
por: Zhou, Yue, et al.
Publicado: (2021)

Using big data to improve cardiovascular care and outcomes in China: a protocol for the CHinese Electronic health Records Research in Yinzhou (CHERRY) Study
por: Lin, Hongbo, et al.
Publicado: (2018)

Study protocol for the evaluation of pharmacist-participated medication reconciliation at county hospitals in China: a multicentre, open-label, assessor-blinded, non-randomised, controlled study
por: Yu, Aichen, et al.
Publicado: (2022)

Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China
por: Guo, Zhigang, et al.
Publicado: (2022)

Trends of Fixed-Dose Combination Antibiotic Consumption in Hospitals in China: Analysis of Data from the Center for Antibacterial Surveillance, 2013–2019
por: Wushouer, Haishaerjiang, et al.
Publicado: (2022)

The effectiveness of influenza vaccine among elderly Chinese: A regression discontinuity design based on Yinzhou regional health information platform
por: Liu, Guangxu, et al.
Publicado: (2022)

Evaluation of prescription review and feedback policy on rational antibiotic use in primary healthcare settings in Beijing, China: a qualitative study using the Theoretical Domains Framework and the behaviour change wheel
por: Wushouer, Haishaerjiang, et al.
Publicado: (2023)

Statins use and risk of new-onset diabetes in hypertensive patients: a population-based retrospective cohort study in Yinzhou district, Ningbo city, People’s Republic of China
por: Li, Hailong, et al.
Publicado: (2018)

Using electronic health record data to establish a chronic kidney disease surveillance system in China: protocol for the China Kidney Disease Network (CK-NET)-Yinzhou Study
por: Wang, Jinwei, et al.
Publicado: (2019)

Anticancer medicines in China: Trends in daily therapy cost and relative procurement volume and spending
por: Huang, Tao, et al.
Publicado: (2021)

Interrupted time-series analysis of the impact of generic market entry of antineoplastic products in China
por: Guan, Xiaodong, et al.
Publicado: (2018)

Trends and patterns of antibiotic consumption in China’s tertiary hospitals: Based on a 5 year surveillance with sales records, 2011-2015
por: Wushouer, Haishaerjiang, et al.
Publicado: (2017)

Does China’s competitive generic substitution policy deliver equivalent clinical outcomes? A pilot study with two generic formulations of olanzepine
por: Zhang, Chao, et al.
Publicado: (2023)

The Cost-Effectiveness of an Intervention Program to Enhance Adherence to Antihypertensive Medication in Comparison With Usual Care in Community Pharmacies
por: Bosmans, Judith E., et al.
Publicado: (2019)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
por: Laio, Kung-Ming, et al.
Publicado: (2023)

Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis
por: Wisløff, Torbjørn, et al.
Publicado: (2012)

Drugs Becoming Generics—The Impact of Genericization on the Market Performance of Antihypertensive Active Pharmaceutical Ingredients
por: Kovács, Bence, et al.
Publicado: (2021)

Generic cardiology drug prices: the potential benefits of the Marc Cuban cost plus drug company model
por: Narendrula, Aparna, et al.
Publicado: (2023)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
por: Jędrusik, Piotr, et al.
Publicado: (2021)

Effects of Antihypertensive Drugs on Thyroid Function in Type 2 Diabetes Patients With Euthyroidism
por: Yang, Lijuan, et al.
Publicado: (2022)

The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
por: Thakkar, Karan B., et al.
Publicado: (2013)

Antihypertensive medications and risk of colorectal cancer in British Columbia
por: Qi, Jia, et al.
Publicado: (2023)

Demonstration of Equivalence of Generic Glatiramer Acetate and Copaxone(®)
por: Lipsky, Peter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4i90ufgr8226bjq2tr356a28h3